Calypso Enterprises Revenue and Competitors
Estimated Revenue & Valuation
- Calypso Enterprises's estimated annual revenue is currently $3.5M per year.
- Calypso Enterprises's estimated revenue per employee is $194,444
Employee Data
- Calypso Enterprises has 18 Employees.
- Calypso Enterprises grew their employee count by -22% last year.
Calypso Enterprises's People
Name | Title | Email/Phone |
---|---|---|
1 | Sales Director | Reveal Email/Phone |
2 | Logistics Manager | Reveal Email/Phone |
3 | General Manager | Reveal Email/Phone |
Calypso Enterprises Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 24 | -8% | N/A | N/A |
#2 | N/A | 32 | 7% | N/A | N/A |
#3 | $3.5M | 15 | -40% | N/A | N/A |
#4 | $75M | 54 | 0% | N/A | N/A |
#5 | $75M | 198 | 1% | N/A | N/A |
#6 | $3.5M | 36 | 0% | N/A | N/A |
#7 | N/A | 89 | 20% | N/A | N/A |
#8 | N/A | 230 | 35% | N/A | N/A |
#9 | N/A | 81 | 9% | N/A | N/A |
#10 | $35M | 158 | 5% | N/A | N/A |
What Is Calypso Enterprises?
Calypso Enterprises is the first grower/processor facility in Erie County to be awarded a permit as part of the Pennsylvania Medical Marijuana Program. Calypso manufactures medical marijuana products for wholesale to licensed dispensaries across the state of Pennsylvania. Through compassion, innovation and excellence, Calypso is dedicated to providing the highest quality medical marijuana products to those in the Commonwealth who suffer from chronic conditions. 💚 To help make our online community the best it can be, please review our social media guidelines: bit.ly/calypsoguidelines
keywords:N/AN/A
Total Funding
18
Number of Employees
$3.5M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 19 | -14% | N/A |
#2 | $1.1M | 19 | -10% | N/A |
#3 | $2M | 20 | -5% | N/A |
#4 | $2M | 20 | 5% | N/A |
#5 | N/A | 20 | -13% | N/A |